Predictive value of immune-related adverse events during pembrolizumab treatment in non-small cell lung cancer.
| Autor: | Valencia Soto, Carmen Maria, Villacañas Palomares, María Victoria, Fernández-Cueto, Adela Garcia-vello, Barbadillo Villanueva, Sara, Martínez Callejo, Virginia, Ochagavía Sufrategui, María, Muñoz Cacho, Pedro, Valero Domínguez, Marta |
|---|---|
| Zdroj: | European Journal of Hospital Pharmacy; Jan2024, Vol. 31 Issue 1, p40-45, 6p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|